Ubs Group Ag Poseida Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 69,717 shares of PSTX stock, worth $662,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,717

Previous 53,623 30.01%

Holding current value

$662,311

Previous $156,000 27.56%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.7 - $4.04 $43,453 - $65,019	16,094 Added 30.01%	69,717 $199,000
Q2 2024 Aug 13, 2024	SELL	$2.0 - $3.46 $43,446 - $75,161	-21,723 Reduced 28.83%	53,623 $156,000
Q1 2024 May 13, 2024	BUY	$2.76 - $4.13 $23,167 - $34,667	8,394 Added 12.54%	75,346 $240,000
Q4 2023 Feb 09, 2024	BUY	$1.83 - $3.51 $56,993 - $109,315	31,144 Added 86.97%	66,952 $224,000
Q3 2023 Nov 09, 2023	SELL	$1.62 - $2.79 $5,520 - $9,508	-3,408 Reduced 8.69%	35,808 $85,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.4 $45,156 - $92,490	27,203 Added 226.45%	39,216 $69,000
Q1 2023 May 12, 2023	BUY	$3.08 - $8.73 $24,147 - $68,443	7,840 Added 187.87%	12,013 $37,000
Q4 2022 Feb 08, 2023	BUY	$3.33 - $6.38 $13,896 - $26,623	4,173 New	4,173 $22,000
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $31,539 - $68,956	-9,795 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.23 - $7.6 $61,022 - $74,442	9,795 New	9,795 $67,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $14,180 - $21,420	-2,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$7.96 - $10.07 $921,624 - $1.17 Million	-115,782 Reduced 98.3%	2,000 $20,000
Q1 2021 May 12, 2021	BUY	$8.51 - $11.91 $82,598 - $115,598	9,706 Added 8.98%	117,782 $1.13 Million
Q4 2020 Feb 11, 2021	BUY	$8.29 - $11.7 $16,505 - $23,294	1,991 Added 1.88%	108,076 $1.19 Million
Q3 2020 Nov 12, 2020	BUY	$8.09 - $16.25 $858,227 - $1.72 Million	106,085 New	106,085 $941,000

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account